CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Enzymatica AB (publ) Company Snapshot
Enzymatica AB (publ) operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Enzymatica AB (publ) with three other pharmaceutical manufacturers in Europe: Collagen Solutions PLC of UNITED KINGDOM (2019 sales of £4.15 million [US$5.19 million] of which 100% was Biomaterials), Nicox SA of FRANCE (6.86 million Euros [US$7.75 million] ), and Marinomed Biotech AG which is based in AUSTRIA (6.14 million Euros [US$6.95 million] of which 100% was Carragelose).

Sales Analysis. During the year ended December of 2019, sales at Enzymatica AB (publ) were SEK 61.31 million (US$6.63 million). This is an increase of 16.6% versus 2018, when the company's sales were SEK 52.56 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Enzymatica AB (publ)
  Stock Performance Chart for Enzymatica AB (publ)
 
  Stock Data: Recent Stock Performance:
  Current Price (7/3/2020): 15.80
(Figures in Swedish Kronor)
1 Week 17.9%   13 Weeks 12.9%  
4 Weeks 97.0%   52 Weeks 225.8%  
 
Enzymatica AB (publ) Key Data:
  Ticker: ENZY Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 61,306,000
(Year Ending Jan 2020).
Employees: 17
  Currency: Swedish Kronor Market Cap: 2,256,614,397
  Fiscal Yr Ends: December Shares Outstanding: 142,823,696
  Share Type: Aktie Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.